There are many published studies on the relationship of the acetylator polymorphism to drug induced disorders. Slow acetylators exhibit toxic reactions to the original unchanged drug compound more frequently than rapid acetylators. In a few clinical situations, however, rapid acetylators fare worse than slow acetylators. A number of publications describe surveys of the acetylator phenotypes in patients with spontaneous disorders. The objective of this article is to evaluate these studies. Methods
POINTS WHICH HAVE TO BE CONSIDERED IN STUDIES OF ASSOCIATIONS BETWEEN THE ACETYLATOR POLYMORPHISM PHENOTYPES AND SPONTANEOUS DISORDERS
(1) Was the disease entity being investigated adequately defined? On the whole it is preferable to have the disease entity defined by some internationally accepted criterion, for example, systemic lupus erythematosus (SLE) as defined by the American Rheumatological Association.1 There was very little value in, for example, publishing the phenotypes of 100 patients with various lung disorders without providing details of the diagnoses.2 (2) Was the ethnic composition of both patient and control grouips defined? D A Price Evans (3) Was the patient sample a stratum (that is, derived from a selected group within the population) ? It is preferable to have as unselected a sample of the disorder being investigated as possible. Sometimes, however, a selection is inevitable, for example, it is possible that a particularly severely afflicted group is studied simply because they attend a special hospital clinic for the disorder under consideration. A group of patients with potential liver damage is alcoholics. Lesteri' showed isoniazid half life data on 28 alcoholics (without ethanol in their blood) and the distribution would appear to be bimodal as in healthy subjects. However, he found that maintenance of 0 02 to 0 04 %Y ethanol in the blood before and during the determination of the half lives resulted in a 30% decrease in the half lives in both groups of subjects. Similarly, Olsen and Morlandl" showed that the presence of about 1 g/l of ethanol in the blood decreased the apparent half life of sulphadimidine by about 20% in both acetylator phenotypes. Olsen and Morland12 showed that ethanol causes a significant reduction in the plasma half life of procainamide with an increase in total clearance. This effect occurs in both phenotypes. The volume of distribution was unaffected.
The position and activity of the subjects being phenotyped may be of importance. For example, Levi et a19 point out that isoniazid half lives in patients with liver disease are increased by about 20 % by the change from lying to walking. On the other hand, pretreatment with other drugs (mainly with barbiturates) has no effect on the distribution curve of isoniazid half lives in normal subjects.
An increased acetylation of sulphadiazine of six undernourished as compared with six well nourished subjects was demonstrated by Shastri and In one series,28 studied with great care, there is a highly significant association between the slow acetylator phenotype and Gilbert's disease (table 2) .
In a study of Graves' disease,29 it was found that the phenotype frequencies did not differ from those in the general population. However, slow acetylators did develop the disease at a significantly younger mean age than rapid acetylators years as compared with 39 5 years). .2wy Weighted mean value of y -Y 0 3290. . Significance of difference of X from unity = X2 -y )2 -6.8170 (p<0-01).
.w Heterogeneity expression is tested byy2 slow acetylators may be more prone than rapid acetylators to develop leprosy (table 9) . Another disorder which merits special consideration is spontaneous systemic lupus erythematosus (SLE). There is a strong association between the slow acetylator phenotype and hydralazine induced SLE (table 10). The idea was therefore promulgated that spontaneous SLE might also be associated with the slow acetylator phenotype. Sufficient information is now available from different ethnographic groups to show that this idea is not tenable (table 11) . Discussion The interpretation of the association between bladder cancer and the slow acetylator phenotype rests upon the knowledge that carcinogenic amines are polymorphically acetylated. 99 Since it is usually survivors undergoing regular cystoscopic examinations who are studied, the acetylator phenotype may be considered either to predispose to the development of the disease or to be a factor leading to enhanced survival (as compared with rapid acetylators). Neither the first nor the second of these explanations can be discounted on the evidence at present available.
With regard to the other associations described with (1) Gilbert's disease, (2) diabetes mellitus, (3) breast cancer, (4) leprosy, and (5) age at onset of Graves' disease, logical interpretation is much more difficult. The natural substrates for the polymorphic N-acetyl-transferase enzyme are unknown. It may be speculated that acetyl accepting molecules, for example aromatic amines or amino-methyl-uracils, may be involved in some way in the production of these four disorders. This present survey may stimulate researchers to investigate such possibilities. 
